US Stock Market Move | STAAR Surgical (STAA.US) surged more than 15% in pre-market trading as Alcon increased its acquisition offer to $1.6 billion.

22:23 09/12/2025

On Tuesday, STAAR Surgical (STAA.US) surged more than 15% in pre-market trading, reaching $27.15.

On Tuesday, STAAR Surgical (STAA.US) soared over 15% in pre-market trading, reaching $27.15. In terms of news, Alcon announced that it has increased its offer to acquire STAAR Surgical to a total equity value of around $1.6 billion, up from the previous $1.5 billion. According to the revised agreement terms, Alcon will purchase all of STAAR Surgical's outstanding shares at a price of $30.75 per share in cash, higher than the previous offer of $28 per share. Alcon stated that this deal represents a 74% premium over STAAR's 90-day volume-weighted average price and a 66% premium over the closing price of STAAR stock on August 4 (the day before the merger announcement).

ZTE Corporation (00763) is currently communicating with the US Department of Justice on relevant matters and will resolutely defend its rights through legal means.

CSPC PHARMA (01093): CSPC Pharma has submitted its listing application to the Hong Kong Stock Exchange.

KONG SUN HOLD (00295): Jiangshan Yongtai will transfer all equity of Datong, Wuhu Tong, Huangshi Huangyuan to Jinan Tianguan

ZTE Corporation (00763) is currently communicating with the US Department of Justice on relevant matters and will resolutely defend its rights through legal means.

CSPC PHARMA (01093): CSPC Pharma has submitted its listing application to the Hong Kong Stock Exchange.

KONG SUN HOLD (00295): Jiangshan Yongtai will transfer all equity of Datong, Wuhu Tong, Huangshi Huangyuan to Jinan Tianguan